NYSE:HTA (USA) Also trade in: Germany

Healthcare Trust of America Inc

$ 27.29 -0.6 (-2.15%)
Volume: 798,884 Avg Vol (1m): 1,315,706
Market Cap $: 5.60 Bil Enterprise Value $: 8.35 Bil
P/E (TTM): 26.75 P/B: 1.84
Earnings Power Value -8.44
Net Current Asset Value -13.36
Tangible Book 12.39
Projected FCF 20.84
Median P/S Value 27.64
Graham Number 16.86
Peter Lynch Value 8.03
DCF (FCF Based) 12.62
DCF (Earnings Based) 10.92
1Y (-%)

Financial Strength : 4.4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.02
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.03, Max: 0.41
Current: 0.02
0
0.41
Equity-to-Asset 0.51
Equity-to-Asset range over the past 10 years
Min: 0.43, Med: 0.51, Max: 0.68
Current: 0.51
0.43
0.68
Debt-to-Equity 0.86
Debt-to-Equity range over the past 10 years
Min: 0.41, Med: 0.85, Max: 1.18
Current: 0.86
0.41
1.18
Debt-to-EBITDA 4.57
Debt-to-EBITDA range over the past 10 years
Min: 4.2, Med: 6.32, Max: 8.24
Current: 4.57
4.2
8.24
Interest Coverage 1.58
Interest Coverage range over the past 10 years
Min: 0.47, Med: 1.47, Max: 1.79
Current: 1.58
0.47
1.79
Piotroski F-Score 8
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.14
DISTRESS
GREY
SAFE
Beneish M-Score -2.52
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 2.65%
WACC 4.75%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 22.75
Operating Margin range over the past 10 years
Min: 10.44, Med: 22.7, Max: 24.89
Current: 22.75
10.44
24.89
Net Margin % 31.49
Net Margin range over the past 10 years
Min: -19.86, Med: 7.88, Max: 31.49
Current: 31.49
-19.86
31.49
ROE % 6.66
ROE range over the past 10 years
Min: -3, Med: 2.09, Max: 6.66
Current: 6.66
-3
6.66
ROA % 3.45
ROA range over the past 10 years
Min: -1.8, Med: 1, Max: 3.45
Current: 3.45
-1.8
3.45
ROC (Joel Greenblatt) % 445.91
ROC (Joel Greenblatt) range over the past 10 years
Min: 1.34, Med: 333.15, Max: 4524.5
Current: 445.91
1.34
4524.5
3-Year Total Revenue Growth Rate 19.90
3-Year Revenue Growth Rate range over the past 10 years
Min: 1.7, Med: 7.65, Max: 48.1
Current: 1.7
1.7
48.1
3-Year Total EBITDA Growth Rate 34.60
3-Year EBITDA Growth Rate range over the past 10 years
Min: 2.1, Med: 15.4, Max: 51.4
Current: 14.1
2.1
51.4
3-Year EPS w/o NRI Growth Rate 57.70
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 57.7
Current: 57.7
0
57.7

» HTA's 30-Y Financials

Financials (Next Earnings Date: 2019-07-23)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:HTA

» Interactive Chart

Peter Lynch Chart

Business Description

Industry REITs » REITs    NAICS : 531190    SIC : 6798
Compare NYSE:MPW NYSE:OHI NYSE:HR NAS:SBRA NYSE:DOC NYSE:NHI NYSE:GEO TSX:CSH.UN NAS:CTRE NAS:SNH LSE:AGR NYSE:LTC SGX:C2PU NYSE:UHT TSX:NWH.UN NYSE:CHCT NZSE:VHP SGX:AW9U NYSE:GMRE NYSE:MRT
Traded in other countries HT01.Germany
Address 16435 North Scottsdale Road, Suite 320, Scottsdale, AZ, USA, 85254
Healthcare Trust of America is a healthcare facility REIT. The company operates one segment, which engages in acquiring and operating medical office buildings. The company generates all of its revenue in the United States. It relies on its in-house leasing platform in order to generate scale, maximize expense efficiency, and build tenant relationships. Its strategy focuses on stable cash flows with relatively low vacancy risk, with consideration of merger and acquisition investment to supplement its operational growth strategy.

Ratios

Current vs industry vs history
PE Ratio (TTM) 26.75
PE Ratio range over the past 10 years
Min: 21.94, Med: 94.75, Max: 234.8
Current: 26.75
21.94
234.8
PE Ratio without NRI 26.75
PE without NRI range over the past 10 years
Min: 21.94, Med: 94.75, Max: 234.8
Current: 26.75
21.94
234.8
Price-to-Owner-Earnings 13.55
Price-to-Owner-Earnings range over the past 10 years
Min: 11.93, Med: 22.56, Max: 32.26
Current: 13.55
11.93
32.26
PB Ratio 1.84
PB Ratio range over the past 10 years
Min: 1.42, Med: 1.97, Max: 2.9
Current: 1.84
1.42
2.9
PS Ratio 8.32
PS Ratio range over the past 10 years
Min: 7.14, Med: 8.42, Max: 10.57
Current: 8.32
7.14
10.57
Price-to-Free-Cash-Flow 23.19
Price-to-Free-Cash-Flow range over the past 10 years
Min: 17.5, Med: 22.85, Max: 29.81
Current: 23.19
17.5
29.81
Price-to-Operating-Cash-Flow 17.60
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 14.97, Med: 18.62, Max: 24.01
Current: 17.6
14.97
24.01
EV-to-EBIT 26.01
EV-to-EBIT range over the past 10 years
Min: 22.2, Med: 55.7, Max: 165.8
Current: 26.01
22.2
165.8
EV-to-EBITDA 13.92
EV-to-EBITDA range over the past 10 years
Min: 12.3, Med: 20.7, Max: 28.8
Current: 13.92
12.3
28.8
EV-to-Revenue 12.14
EV-to-Revenue range over the past 10 years
Min: 10.6, Med: 12.5, Max: 16.9
Current: 12.14
10.6
16.9
PEG Ratio 3.28
PEG Ratio range over the past 10 years
Min: 2.9, Med: 6.61, Max: 14.08
Current: 3.28
2.9
14.08
Shiller PE Ratio 62.49
Shiller PE Ratio range over the past 10 years
Min: 58.7, Med: 64.22, Max: 66.88
Current: 62.49
58.7
66.88
Current Ratio 1.81
Current Ratio range over the past 10 years
Min: 0.89, Med: 1.8, Max: 6.92
Current: 1.81
0.89
6.92
Quick Ratio 1.81
Quick Ratio range over the past 10 years
Min: 0.89, Med: 1.8, Max: 6.92
Current: 1.81
0.89
6.92
Days Sales Outstanding 60.04
Days Sales Outstanding range over the past 10 years
Min: 17.28, Med: 63.68, Max: 72.73
Current: 60.04
17.28
72.73

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 4.54
Trailing Dividend Yield range over the past 10 years
Min: 0.48, Med: 4.32, Max: 5.82
Current: 4.54
0.48
5.82
Dividend Payout Ratio 1.20
Dividend Payout Ratio range over the past 10 years
Min: 1.2, Med: 3.58, Max: 5.48
Current: 1.2
1.2
5.48
3-Year Dividend Growth Rate (Per Share) 1.70
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0.55, Max: 20.4
Current: 1.7
0
20.4
Forward Dividend Yield % 4.54
N/A
Yield-on-Cost (5-Year) % 4.88
Yield-on-Cost (5y) range over the past 10 years
Min: 0.51, Med: 4.63, Max: 6.24
Current: 4.88
0.51
6.24
3-Year Share Buyback Rate -18.30
3-Year Share Buyback Rate range over the past 10 years
Min: -18.3, Med: -4.35, Max: 1.5
Current: -18.3
-18.3
1.5

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 2.20
Price-to-Tangible-Book range over the past 10 years
Min: 1.93, Med: 2.8, Max: 4.03
Current: 2.2
1.93
4.03
Price-to-Projected-FCF 1.31
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.2, Med: 1.37, Max: 2.42
Current: 1.31
1.2
2.42
Price-to-DCF (Earnings Based) 2.50
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 2.34, Med: 2.48, Max: 2.62
Current: 2.5
2.34
2.62
Price-to-Median-PS-Value 0.99
Price-to-Median-PS-Value range over the past 10 years
Min: 0.84, Med: 0.99, Max: 1.19
Current: 0.99
0.84
1.19
Price-to-Peter-Lynch-Fair-Value 3.40
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 2.9, Med: 6.75, Max: 13.92
Current: 3.4
2.9
13.92
Price-to-Graham-Number 1.62
Price-to-Graham-Number range over the past 10 years
Min: 1.47, Med: 3.63, Max: 5.22
Current: 1.62
1.47
5.22
Earnings Yield (Joel Greenblatt) % 3.86
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0.6, Med: 1.8, Max: 4.5
Current: 3.86
0.6
4.5
Forward Rate of Return (Yacktman) % 12.21
Forward Rate of Return range over the past 10 years
Min: -1.5, Med: 15.4, Max: 24.4
Current: 12.21
-1.5
24.4

More Statistics

Revenue (TTM) (Mil) $ 689.34
EPS (TTM) $ 1.02
Beta 0.42
Volatility % 20.72
52-Week Range $ 24.21 - 29.39
Shares Outstanding (Mil) 205.1

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 8
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N